Immix Biopharma (IMMX) Stock Price
Immix Biopharma Price
The consensus 12-month price target for Immix Biopharma is 22.00 USD, about 163.3% above where the stock trades today. Of 13 analysts, 12 rate the stock a buy — an overall Buy consensus.
Immix Biopharma stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Immix Biopharma business model & stock analysis
Frequently asked questions about Immix Biopharma
Analysts currently set an average price target of 22.00 USD for the Immix Biopharma stock (median: 22.00 USD), implying +163.3 % versus the latest price. The consensus is based on 13 analyst ratings.
13 analysts currently rate the Immix Biopharma stock: 12 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Immix Biopharma to generate revenue of 12.14 M USD and earnings per share of -0.97 USD.
Converted at the current exchange rate, the Immix Biopharma share trades at 7.45 EUR (8.35 USD).
The Immix Biopharma share (IMMX) is listed on 1 stock exchanges, including: NASDAQ (IMMX).
The expected revenue of Immix Biopharma is 12.14 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Immix Biopharma is -37.22 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Immix Biopharma is currently -8.59. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Immix Biopharma stock.
The price-to-sales ratio (P/S) of Immix Biopharma is currently 26.35. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Immix Biopharma stock.
The Eulerpool Quality Score for Immix Biopharma is 2/10.
The ISIN of Immix Biopharma is US45258H1068. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Immix Biopharma is IMMX. The ticker symbol is used to trade Immix Biopharma shares on the stock exchange.
Immix Biopharma stock
Immix Biopharma Peer Group
Immix Biopharma Ticker
Immix Biopharma FIGI
All fundamentals and in-depth analysis of Immix Biopharma
Our stock analysis for Immix Biopharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Immix Biopharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.